Skip to product information
1 of 1

Investigational triple-receptor agonist research peptide

META-X Retatrutide Research Pen

META-X Retatrutide Research Pen

Retatrutide (LY3437943)

Regular price Dhs. 0.00 AED
Regular price Sale price Dhs. 0.00 AED
Sale Sold out
Strength
Quantity

META-X contains retatrutide, an investigational acylated peptide studied in controlled laboratory models of glucagon, GLP-1 and GIP receptor signaling. The supplied artwork declares one 3 mL pre-filled research pen containing 30 mg or 60 mg total.

Specifications

Active material
Retatrutide (LY3437943)
Declared presentation
30 mg or 60 mg total per pen
Container
3 mL nominal cartridge, one pre-filled pre-mixed pen
CAS number(s)
2381089-83-2
Molecular formula
C221H342N46O68
Sequence / structure
39-residue acylated synthetic peptide containing non-natural residues and a lipid side chain
Synonyms
LY3437943; triple GCGR/GLP-1R/GIPR agonist

What this material is studied for

  • GCGR, GLP-1R and GIPR receptor-binding and functional signaling assays.
  • Multi-agonist structure-activity, receptor-bias and cAMP-response research.
  • Metabolic signaling and energy-balance models conducted under approved laboratory protocols.

Scientific context

Retatrutide is designed to activate the glucagon receptor (GCGR), the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR). Research applications include comparative receptor pharmacology, cAMP signaling, structure-activity relationships and metabolic-pathway studies in validated experimental systems.

Storage and handling

Store a mixed or in-use research pen refrigerated at 2–8 °C (36–46 °F). Keep unused pens cold until their expiry date, protect them from direct light, and never freeze them.

Disclaimer

For laboratory research use only. Not for human or veterinary use. Not a food, drug, cosmetic or dietary supplement. Not intended to diagnose, treat, cure or prevent any disease. Purchasers are responsible for lawful handling and use by qualified personnel.

View full details